BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 19339790)

  • 1. Overnight levels of luteinizing hormone, follicle-stimulating hormone and growth hormone before and during gonadotropin-releasing hormone analogue treatment in short boys born small for gestational age.
    van der Kaay DC; de Jong FH; Rose SR; Odink RJ; Bakker-van Waarde WM; Sulkers EJ; Hokken-Koelega AC
    Horm Res; 2009; 71(5):260-7. PubMed ID: 19339790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced levels of GH during GnRH analogue treatment in pubertal short girls born small for gestational age (SGA).
    van der Kaay DC; Rose SR; van Dijk M; Noordam C; van Rheenen E; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):914-9. PubMed ID: 19178519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overnight luteinizing and follicle stimulating hormone profiles during GnRHa treatment in short girls born small for gestational age.
    van der Kaay DC; de Jong FH; Laven JS; Hokken-Koelega AC
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):161-9. PubMed ID: 19449673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
    Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
    Kanety H; Karasik A; Pariente C; Kauschansky A
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testis function in prepubertal boys and young men born small for gestational age.
    Boonstra VH; Weber RF; de Jong FH; Hokken-Koelega AC
    Horm Res; 2008; 70(6):357-63. PubMed ID: 18953173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F; Federico G; Harrell JC; Saggese G
    Neuroendocrinology; 2009; 90(3):307-14. PubMed ID: 19641297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized GH trial with two different dosages in combination with a GnRH analogue in short small for gestational age children: effects on metabolic profile and serum GH, IGF1, and IGFBP3 levels.
    van der Kaay D; Bakker B; van der Hulst F; Mul D; Mulder J; Schroor E; van Elswijk D; Rowaan I; Willeboer M; de Ridder M; Hokken-Koelega A
    Eur J Endocrinol; 2010 May; 162(5):887-95. PubMed ID: 20176737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW; Willemsen RH; van der Kaay DC; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA; Rothenberg S; Blumberg D; Oberfield SE; Levine LS; David R
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
    Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
    Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.